Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Effixis provides end-to-end artificial intelligence and data analytics solutions for businesses across multiple industries. It specializes in Natural Language Processing (NLP), Large Language Models (LLMs), Generative AI, and related technologies. The company was acquired by Artefact in September 2024 to enhance Artefact’s AI consulting capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Effixis.